Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada.

L'Huillier AG, Eshaghi A, Racey CS, Ogbulafor K, Lombos E, Higgins RR, Alexander DC, Kristjanson E, Maregmen J, Gubbay JB, Mazzulli T.

Virol J. 2018 Jun 5;15(1):98. doi: 10.1186/s12985-018-0996-5.

2.

Evaluation of Euroimmun Anti-Zika Virus IgM and IgG Enzyme-Linked Immunosorbent Assays for Zika Virus Serologic Testing.

L'Huillier AG, Hamid-Allie A, Kristjanson E, Papageorgiou L, Hung S, Wong CF, Stein DR, Olsha R, Goneau LW, Dimitrova K, Drebot M, Safronetz D, Gubbay JB.

J Clin Microbiol. 2017 Aug;55(8):2462-2471. doi: 10.1128/JCM.00442-17. Epub 2017 May 31.

3.

Evaluation of Altona Diagnostics RealStar Zika Virus Reverse Transcription-PCR Test Kit for Zika Virus PCR Testing.

L'Huillier AG, Lombos E, Tang E, Perusini S, Eshaghi A, Nagra S, Frantz C, Olsha R, Kristjanson E, Dimitrova K, Safronetz D, Drebot M, Gubbay JB.

J Clin Microbiol. 2017 May;55(5):1576-1584. doi: 10.1128/JCM.02153-16. Epub 2017 Mar 15.

4.

Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population.

Trotz-Williams LA, Mercer NJ, Paphitis K, Walters JM, Wallace D, Kristjanson E, Gubbay J, Mazzulli T.

Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00542-16. doi: 10.1128/CVI.00542-16. Print 2017 Feb.

5.

Epidemiology of Enterovirus D68 in Ontario.

Peci A, Winter AL, Warshawsky B, Booth TF, Eshaghi A, Li A, Perusini S, Olsha R, Marchand-Austin A, Kristjanson E, Gubbay JB.

PLoS One. 2015 Nov 23;10(11):e0142841. doi: 10.1371/journal.pone.0142841. eCollection 2015.

6.

Acute Respiratory Infections in Travelers Returning from MERS-CoV-Affected Areas.

German M, Olsha R, Kristjanson E, Marchand-Austin A, Peci A, Winter AL, Gubbay JB.

Emerg Infect Dis. 2015 Sep;21(9):1654-6. doi: 10.3201/eid2109.150472.

7.

Population-based passive tick surveillance and detection of expanding foci of blacklegged ticks Ixodes scapularis and the Lyme disease agent Borrelia burgdorferi in Ontario, Canada.

Nelder MP, Russell C, Lindsay LR, Dhar B, Patel SN, Johnson S, Moore S, Kristjanson E, Li Y, Ralevski F.

PLoS One. 2014 Aug 29;9(8):e105358. doi: 10.1371/journal.pone.0105358. eCollection 2014.

8.

Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.

Winter AL, Peci A, Eshaghi A, Baird M, Memari N, Kristjanson E, Balogun E, Higgins RR, Li A, Farrell DJ, Gubbay JB.

Infect Control Hosp Epidemiol. 2013 Nov;34(11):1225-8. doi: 10.1086/673455. Epub 2013 Sep 25.

PMID:
24113612
9.

Respiratory viral infections in institutions from late stage of the first and second waves of pandemic influenza A (H1N1) 2009, Ontario, Canada.

Asner S, Peci A, Marchand-Austin A, Winter AL, Olsha R, Kristjanson E, Low DE, Gubbay JB.

Influenza Other Respir Viruses. 2012 May;6(3):e11-5. doi: 10.1111/j.1750-2659.2012.00336.x. Epub 2012 Feb 21.

10.

An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.

Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, Fung C, Crowcroft NS.

CMAJ. 2011 Jun 14;183(9):1014-20. doi: 10.1503/cmaj.101371. Epub 2011 May 16.

Supplemental Content

Loading ...
Support Center